CollPlant is Developing 3D-bioprinted Implants for Regeneration of Breast Tissue

REHOVOT, Israel, Aug. 5, 2019 -- (Healthcare Sales & Marketing Network) -- CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative medicine company, announced today that it is developing 3D bioprinted implants for regeneration of breast tissue ... Regenerative Medicine CollPlant, 3D bioprinting, recombinant human collagen
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news